Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2010 | 07-2009 | 07-2008 | 07-2007 | 07-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,280 | -45,812 | -36,229 | -23,505 | -67,967 |
| Depreciation Amortization | 2,546 | 17,455 | 4,774 | 1,775 | 17,095 |
| Accounts receivable | -13 | 14 | -31 | -57 | N/A |
| Other Working Capital | 2,101 | 258 | -468 | 1,515 | 3,790 |
| Other Operating Activity | -1,666 | 5,438 | 3,645 | 3,041 | 36,509 |
| Operating Cash Flow | $-22,312 | $-22,648 | $-28,310 | $-17,231 | $-10,573 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 8,852 | 5,160 | 361 | -14,373 |
| PPE Investments | -160 | -1 | -57 | -94 | -150 |
| Purchase Sale Intangibles | -229 | -152 | -233 | -209 | -114 |
| Other Investing Activity | -229 | -152 | -182 | -405 | 73 |
| Investing Cash Flow | $-389 | $8,699 | $4,921 | $-138 | $-14,449 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 20,450 | N/A | 13,955 |
| Debt Issued | 0 | N/A | N/A | N/A | 36 |
| Debt Repayment | -140 | -118 | -90 | -73 | -572 |
| Common Stock Issued | 22,474 | 15,618 | 392 | 427 | 49,579 |
| Common Stock Repurchased | N/A | N/A | -379 | N/A | N/A |
| Other Financing Activity | 0 | -4,507 | -723 | -174 | -347 |
| Financing Cash Flow | $22,334 | $10,994 | $19,651 | $179 | $62,650 |
| Exchange Rate Effect | 50 | -85 | -51 | 7 | -5 |
| Beginning Cash Position | 14,197 | 17,238 | 21,026 | 38,209 | 587 |
| End Cash Position | 13,881 | 14,197 | 17,238 | 21,026 | 38,209 |
| Net Cash Flow | $-316 | $-3,041 | $-3,789 | $-17,182 | $37,622 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,312 | -22,648 | -28,310 | -17,231 | -10,573 |
| Capital Expenditure | -160 | -1 | -57 | -94 | -150 |
| Free Cash Flow | -22,472 | -22,649 | -28,367 | -17,325 | -10,723 |